5-Year Overall Survival In Columbus: A Randomized Phase 3 Study Of Encorafenib Plus Binimetinib Versus Vemurafenib Or Encorafenib In Patients With Braf(V600)-Mutated Melanoma
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要